ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 265

Reducing Loads in the Contralateral Side in Medial Knee Osteoarthritis; A 3-Year Follow-up Study

Roy H. Lidtke and Joel A. Block, Section of Rheumatology, Rush University Medical Center, Chicago, IL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: biomechanical testing and osteoarthritis, Knee

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: No strategies have been shown to prevent Medial knee osteoarthritis (MKOA).  For those with symptomatic unilateral MKOA, the contralateral knee may be at risk for developing MKOA.  Early adaptation of load reducing strategies may reduce the development of the disease in the contralateral knee. 

Methods:

90 subjects (69F 21M, Age 60±8, BMI 28.3±4.0) with radiographic and symptomatic medial knee OA (K-L grade 2-3, ambulatory pain >30 mm on a 100 mm VAS) were randomized into a control group fitted with bilateral neutral foot orthosis or a treatment group fitted with 7 degree valgus posted foot orthosis.  The knee joint with greater pain was labeled as the index side.  Subjects underwent gait analyses using an optoelectronic camera system and multi-component force plate. Subjects walked at their normal speed, and comparisons were performed after matching for speed. The peak external knee Adduction Moment (KAddM) (%body weight * height, %BW*Ht) was calculated and used as the primary endpoint. Subjects were evaluated at baseline and again at 36 months with and without the orthosis.  Changes in the peak KAddM between conditions and time variable were calculated and expressed as a percentage change in the control condition.  Nonparametric confidence intervals were calculated with the binomial method around the percentage of change to assess statistical significance with significance set at p<0.05.

Results:

After 3 years the contralateral knee showed a 5.01±0.09% (Median±IQR) increase in medial knee load when the control orthosis was added while there was a (-)5.29±0.72% (Median±IQR) decrease in the medial knee load with the addition of the wedge orthosis in the treatment group.  In the wedge treatment group the median drop in knee adduction moments between baseline and 36 months was (-)7.61±0.84% in the contralateral knee and (-)6.49±0.13% on the index side (Median±IQR).  Interestingly After 3 years in the control treatment group there was a 10.66±0.52%  increase in the medial knee loads on the index side while there was a (-)11.29±0.74%  decrease in the medial knee loads on the contralateral side (Median±IQR).

Conclusion:

The contralateral knee may be at risk in subjects with MKOA.  These data suggest that the contralateral knee may get better benefit using load reducing strategies such as valgus wedge foot orthosis.  The greatest sustained reduction of knee loads was seen in the contralateral knee of the control group.  Since the control group was wearing custom foot orthosis posted to perpendicular to the ground it may be that a non-valgus posted custom foot orthosis on the contralateral side may be of benefit for reducing the progression of knee osteoarthritis.


Disclosure:

R. H. Lidtke,
None;

J. A. Block,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reducing-loads-in-the-contralateral-side-in-medial-knee-osteoarthritis-a-3-year-follow-up-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology